NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Elogium Probiotics

Elogium Probiotics

Private
RigaHealthcare & Life Scienceshttp://elogium.bio/

Last Round

Grant

Jun 26, 2025

Total Funding Raised

$594,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Elogium Probiotics is a biotechnology company that develops a probiotic feed additive for the poultry industry designed to combat pathogens and improve growth.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

probiotic feed additiveanimal healthfood safetyantibiotic alternativepathogen controlpoultry probioticsagritechagtechnatural growth promoterBacillus subtilisanimal nutritionCampylobacter reductionSalmonella reductionlivestock feed additivefeed conversion ratioswine probiotics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Elogium Probiotics Comparables

Compare Elogium Probiotics with similar companies based on industry and business-model similarity.

Elogium Probiotics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Elogium Probiotics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 26, 2025
SeedFeb 16, 2023
Pre SeedSep 10, 2021
View all Funding Rounds

Key People

Founding team and executive leadership

Katarina Šimunović

Chief Technology Officer And Co-founder

Founding Team

Karlis Udris

Chief Executive Officer, Co-Founder

Founding Team

Elogium Probiotics Investors

Notable investors and investment history

Elogium Probiotics investors
InvestorRounds
Biotope by VIBSeed, Pre Seed
European Regional Development FundGrant
SIA “Farmācijas, biomedicīnas un medicīnas tehnoloģiju Kompetences centrs”Grant
Commercialization ReactorSeed, Pre Seed
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors increased 34% MoM.

  • Jun 26, 2025

    Secured $427K from European Regional Development Fund and SIA “Farmācijas, biomedicīnas un medicīnas tehnoloģiju Kompetences centrs”.

View all signals

Elogium Probiotics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Elogium Probiotics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Elogium Probiotics's valuation, stock price, and market status.

Firmographic Details

HeadquartersRiga
Employee Range4
Year Founded2021
Last FundingJun 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.